TrialDrug design, development and therapy2015

Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance.

Steen Lindkær-Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.